#WMIF2020

Digital Therapeutics Hadine Joffe, MD

Paula A. Johnson Professor, Women’s Health, HMS Priya Abani, CEO, AliveCor Julia Hu, CEO, Lark Health Dawn Sugarman, PhD

#WMIF2020

Julia Hu, CEO, Lark Health AI 24×7 counseling data streaming in data TeleHealth VirtualHealth Provider – working hard to scale

#WMIF2020

Transportation and elevators – social distancing – impossible Global change enormous Telemedicine ramp up Academic center Telemedicine will prevail  more resilient Health care system dialogue and communications across countries

#WMIF2020

Work from home – productivity is good, work from home not ideal environment Transportation and elevators – social distancing – impossible

#WMIF2020

Matt Sause, President and CEO, Roche Diagnostics Corporation Serology – more people become infected active infection Partnership between FDA and the manufactures In the US scaling – infrastructure in place is a must

#WMIF2020

Marc Casper CEO

Supply chain, more preparedness, robustness of the supply chain Buying supply in China vs US based stockpiling by governments not only at the Hospital level vs JIT shocks to the system

#WMIF2020

Marc Casper CEO

Re-opening the economy requires Testing for certification of health Testing bringing confidence  PCR – have or have not viral proteins: 5Millions a week, June 10 million tests antibody testing

#WMIF2020

James Brink, MD, Radiology, MGH; Juan M. Taveras Professor of Radiology, HMS social determinant of care – communities not able to social distance, multiple languages Radiology: Rapid evolution of pandemic MGB – Standardizations

#WMIF2020

Michel Vounatsos, CEO, Biogen Venture community supportive to be on the safe side  employees tested every evenings to prevent rebound of the pandemic Pandemic is acceleration progress technologies new drugs Biogen will lead new model

#WMIF2020

Keeping Priority on the Biggest Diseases Moderator: Jean-François Formela, MD, Partner, Atlas Venture Michel Vounatsos, CEO, Biogen Short term $10Billion dedicated to research Blood Bank and

donation Antibody

#WMIF2020

Amy Abernethy, MD, PhD, Principal Deputy Commissioner & Acting CIO, FDA Future – common tools, more efficient studies study protocols and study design evaluation efficient processes are alter become more effective global WHO NIH CDC

#WMIF2020

FDA Role in Managing Crisis and Anticipating the Next Ravi Thadhani, MD, CAO

Panel: Amy Abernethy, MD, PhD

Lindsey Baden, MD

#regulatory flexibility during the pandemic on drugs and on #serology #testing

#WMIF2020

Lindsey Baden, MD, Director

Identify diagnostics for clinical definition of a virus unknown treatment to be developed Sick patients in need for treatment clinicians need the Tx FDA and the hospitals are flexible in responding

#WMIF2020

#AI need be combined with #ML and #NLP grass roots organization show the way not the technology will be a driver

#WMIF2020

Calibrating Innovation Opportunity and Urgency: Medical Social Natasha Singer

Panel: Giles Boland, MD, Radiology

Amit Phadnis

Krishna Yeshwant, MD

#social #determinants of #Health #policy contact tracing

#WMIF2020

General (Ret) Keith Alexander, Co-CEO, IronNet Cybersecurity #cyberattacks thousands work on #vaccine #alert on #crime and stealing #intellectual #property working together #collective #defense

#WMIF2020

#Health #security vs #network security getting down a medical #infection by #SocialDistancing #ContactTracing #vaccine development share information without #identification of the data owner sharing #behavior of #threat #data

#WMIF2020

Insights on Pandemics and Health Care from the National Security Community General (Ret) Keith Alexander, Co-CEO, IronNet Cybersecurity #Speed #Information #DataAnalytics #HumanGenome data Cancer data #big data for training models